Suchergebnisse - "Cristóvão, Paula"

PubPharm (15)

1

Detection of Abnormal Prion Protein by Immunohistochemistry

enthalten in: Journal of visualized experiments : JoVE | 2023

von Orge, L. | Lurdes Pinto, M. | Cristovão, P. | +9

2

Interim 2019/20 influenza vaccine effectiveness : six European studies, September 2019 to January 2020

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2020

von Rose, A. | Kissling, E. | Emborg, H. | +108

3

Epidemiology and genetic variability of respiratory syncytial virus in Portugal, 2014-2018

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2019

von Sáez-López, E. | Cristóvão, P. | Costa, I. | +27

4

Performance of surveillance case definitions for respiratory syncytial virus infections through the sentinel influenza surveillance system, Portugal, 2010 to 2018

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2019

von Sáez-López, E. | Pechirra, P. | Costa, I. | +5

5

Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828-4835

enthalten in: Vaccine | 2018

von Melidou, A. | Broberg, E. | European region influenza surveillance network | +100

ErratumFor: Vaccine. 2017 Sep 5;35(37):4828-4835. - PMID 28780977

6

Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal

enthalten in: Vaccine | 2017

von Guiomar, R. | Pereira da Silva, S. | Conde, P. | +35

7

Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2) : I-MOVE multicentre case control studies at primary care and hospital levels in Europe

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2017

von Kissling, E. | Rondy, M. | I-MOVE/I-MOVE+ study team | +100

8

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2016

von Valenciano, M. | Kissling, E. | Reuss, A. | +44

ErratumIn: Euro Surveill. 2016;21(8). doi: 10.2807/1560-7917.ES.2016.21.8.30145. - PMID 26939540

9

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2016

von Broberg, E. | Melidou, A. | Prosenc, K. | +103

10

Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries

enthalten in: Epidemiology and infection | 2015

von Beauté, J. | Zucs, P. | Korsun, N. | +38